Literature DB >> 10323328

Zoxazolamine-induced paralysis in two rat substrains: differences in hepatic drug metabolism.

P Pappas1, P Stephanou, V Vasiliou, M Marselos.   

Abstract

Aldehyde dehydrogenase (ALDH) is involved in the metabolism of endogenous and exogenous aldehydes originating from biogenic amines, lipids, food and drugs. Rat liver contains at least two cytosolic ALDHs that can be stimulated by inducers of drug metabolism. Phenobarbital- type inducers increase ALDH1 activity while polycyclic aromatic hydrocarbons (such as benzo[alpha]pyrene) and 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) increase ALDH3c isoenzyme activity. Two rat substrains were isolated according to a different induction of hepatic ALDH after treatment with phenobarbital (PB). Animals that responded to treatment (RR) and those that did not respond (rr) were inbred and divided into two homogenous groups. These animals constituted an ideal experimental model due to their common origin. Apart from the dramatic induction of cytosolic ALDH1 and ALDH3c, the effects of PB on pentoxy-, ethoxy- and methoxy-resorufin-O-dealkylase (P-, E-, and MROD) between the two substrains were also studied. 3-Methylcholanthrene (3MC) greatly increased ALDH3c levels in both substrains, although it was slightly more pronounced in the rr rats, in which it was assessed either as ALDH3c or as total cytosolic ALDH. A similar trend was also noted in EROD, PROD and MROD activities. Dealkylation of the methoxy group was found to be statistically different between the two substrains (rr > RR). The relevance of the biochemical findings with the in vivo hepatic capacity for drug metabolism was investigated by measuring the duration of zoxazolamine paralysis. Both animal substrains were tested with zoxazolamine either without pretreatment or after administration of PB or 3MC: the paralysis produced by zoxazolamine lasted for a longer period in rr than in RR rats. After pretreatment with PB, the duration of paralysis was greatly reduced, but the differences between the two substrains remained. Pretreatment with various doses of 3MC produced differences in the duration of paralysis in RR and rr rats, although the time period was much shorter than that observed in control animals.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 10323328     DOI: 10.1007/BF03189996

Source DB:  PubMed          Journal:  Eur J Drug Metab Pharmacokinet        ISSN: 0378-7966            Impact factor:   2.569


  16 in total

1.  Inherent specificities of purified cytochromes P-450 and P-448 toward biphenyl hydroxylation and ethoxyresorufin deethylation.

Authors:  M D Burke; R T Mayer
Journal:  Drug Metab Dispos       Date:  1975 Jul-Aug       Impact factor: 3.922

Review 2.  Disposition of hexobarbital: 15 years of an intriguing model substrate.

Authors:  M van der Graaff; N P Vermeulen; D D Breimer
Journal:  Drug Metab Rev       Date:  1988       Impact factor: 4.518

3.  Substrate preference of a cytosolic aldehyde dehydrogenase inducible in rat liver by treatment with 3-methylcholanthrene.

Authors:  M Marselos; R Lindahl
Journal:  Toxicol Appl Pharmacol       Date:  1988-09-15       Impact factor: 4.219

4.  Genetic aspects of increase in rat liver aldehyde dehydrogenase induced by phenobarbital.

Authors:  R A Deitrich
Journal:  Science       Date:  1971-07-23       Impact factor: 47.728

5.  Genetic expression of aryl hydrocarbon hydroxylase induction. Presence or absence of association with zoxazolamine, diphenylhydantoin, and hexobarbital metabolism.

Authors:  J R Robinson; D W Nebert
Journal:  Mol Pharmacol       Date:  1974-05       Impact factor: 4.436

6.  Genetic variation of drug-metabolizing enzymes in the wistar rat.

Authors:  M Marselos
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1976-08

7.  Cyp1a2(-/-) null mutant mice develop normally but show deficient drug metabolism.

Authors:  H C Liang; H Li; R A McKinnon; J J Duffy; S S Potter; A Puga; D W Nebert
Journal:  Proc Natl Acad Sci U S A       Date:  1996-02-20       Impact factor: 11.205

Review 8.  Aldehyde dehydrogenases and their role in carcinogenesis.

Authors:  R Lindahl
Journal:  Crit Rev Biochem Mol Biol       Date:  1992       Impact factor: 8.250

9.  Phenobarbital enhances the aldehyde dehydrogenase activity of rat hepatocytes in vitro and in vivo.

Authors:  M Marselos; G Michalopoulos
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1986-11

10.  Tissue distribution of inducible aldehyde dehydrogenase activity in the rat after treatment with phenobarbital or methylcholanthrene.

Authors:  V Vasiliou; M Marselos
Journal:  Pharmacol Toxicol       Date:  1989-01
View more
  1 in total

1.  Restoration of chaperone-mediated autophagy in aging liver improves cellular maintenance and hepatic function.

Authors:  Cong Zhang; Ana Maria Cuervo
Journal:  Nat Med       Date:  2008-09       Impact factor: 53.440

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.